Fariba Navid

Trials

Studies that name Fariba Navid as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:03 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT05068583 · Liquid Biopsies in Pediatric Solid Tumors

  Children's Hospital Los Angeles · recruiting · Pediatric Solid Tumor, Unspecified, Protocol Specific · principal investigator
• Ph2
  NCT04195399 · A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery

  Children's Oncology Group · active not recruiting · Desmoid Fibromatosis, Recurrent Desmoid Fibromatosis, Unresectable Desmoid Fibromatosis · principal investigator
• Ph2
  NCT01222767 · Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy

  PharmaMar · completed · Ewing's Sarcoma, Primitive Neuroectodermal Tumor (PNET), Askin's Tumor of the Chest Wall · principal investigator
• Ph2
  NCT00145639 · Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma

  St. Jude Children's Research Hospital · completed · Osteosarcoma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 08:03 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• COG NCTN Network Group Operations Center
  U10CA180886 · NCI · COG RESEARCH FOUNDATION, LLC · PI Douglas S. Hawkins · fiscal years 2014 to 2026
  Named on NCT04195399